|
The company's manufacturing facility covers, Cephalosporin, Carbapenem and Oncology (liquid& lyophilized injectable) formulations. The company had received its first EU GMP certification in 2007. It has consistently maintained a robust presence in the European market for over 15 years. As one of the leading exporters of Meropenem outside India and with multiple marketing aithoriszations across Europe. Venus Remedies is a global pharmaceutical company with a strong focus on fixed dosage injectables. It has a wide range of products and is present in many countries around the world. The company is also committed to research and innovation. The company's consolidated net profit declined 64.7% YoY to Rs 3.51 crore in Q2 FY25. Net sales fell marginally 0.2% to Rs 167.45 crore in Q2 FY25 as compared with Rs 167.72 crore in Q2 FY24. Powered by Capital Market - Live News
|